The DEEP project has received research funding from the European Union under the 7th Framework Programme

interview

The ApoPharma point of view: interview to Dr. Michael Spino

marzo 25, 2016
|
Comments off
|

The DEEP Project has already brought forth its first results and is continuing along the challenging path of a large multinational clinical trial. At this point, which is now in the final stage, we asked Dr. Michale Spino, President of ApoPharma Inc. to describe the major contribution provided […]

Share
Read more →

Performing a paediatric clinical study in Tunisia: interview to Prof. Mohamed Bejaoui

marzo 25, 2016
|
Comments off
|

Paediatric trials have a default level of complexity, that is depending on regulatory, methodological, ethical and administrative issues, especially when they are registrative and international as DEEP-2 is.

DEEP-2 is, in fact, a multi-national and multi-center clinical trial involving not only a paediatric multi […]

Share
Read more →

DEEP-3 at a glance: interview to Prof. Antje Neubert

marzo 25, 2016
|
Comments off
|

DEEP-3 is a long-term observational safety study which evaluates the nature and incidence of adverse effects of deferiprone (DFP) in children and adolescents with beta-thalassaemia major by conducting a multi-centre, multi-national, observational cohort study with both retrospective (using chart review) and prospective data […]

Share
Read more →